- CA$38.61m
- CA$71.59m
- CA$65.29m
- 58
- 91
- 69
- 85
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.24 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 3.04 | ||
| Price to Sales | 0.51 | ||
| EV to EBITDA | 3.69 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 29.99% | ||
| Return on Equity | 19.84% | ||
| Operating Margin | 14.87% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 4.88 | 5.31 | 10.56 | 26.67 | 65.29 | n/a | n/a | 81.79% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
MTL Cannabis Corp. is focused on crafting cannabis products, including lines of dried flower, pre-rolls and hash marketed. The Company, through its subsidiaries, is engaged in the cultivation and production of cannabis products for recreational and medical purposes in Canada. It also operates clinics that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from medical conditions. Its wholly owned subsidiaries include Montreal Medical Cannabis Inc. (Montreal Cannabis), Abba Medix Corp. (Abba), Canada House Clinics Inc. (CHC), and IsoCanMed Inc. (ICM). Montreal Medical is a licensed producer operating from a 57,000 sq ft licensed indoor growing facility in Pointe Claire, Quebec. Abba is a licensed producer in Pickering, Ontario that operates a medical cannabis marketplace. CHC is operating clinics across Canada. ICM is a licensed producer in Louiseville, Quebec growing indoor cannabis in its 64,000 sq. ft. production facility.
Directors
- Christopher Churchill-Smith CEO
- Paul Hart CFO
- Fabian Daniel Henry CEX
- Michael Orrbrooke CEX
- Alex Kroon EVP
- David Shpilt VPR
- Steven Pearce VPR
- Norman Betts DRC (67)
- Shawn Graham DRC
- Gaetan Lussier DRC
- Dennis Moir DRC
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 31st, 1995
- Public Since
- June 27th, 2000
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Canadian Securities Exchange- Shares in Issue
- 116,997,561
- Address
- 1773 Bayly St, PICKERING, L1W 2Y7
- Web
- https://mtlcorp.ca/
- Phone
- Auditors
- MNP LLP
Upcoming Events for MTLC
Q1 2026 MTL Cannabis Corp Earnings Release
Similar to MTLC
4Front Ventures
Canadian Securities Exchange
Ascend Wellness Holdings
Canadian Securities Exchange
Ayr Wellness
Canadian Securities Exchange
Braxia Scientific
Canadian Securities Exchange
Craftport Cannabis
Canadian Securities Exchange
FAQ
What is the MTL Cannabis share price?
As of Today at 22:09 UTC, shares in MTL Cannabis are trading at CA$0.33. This share price information is delayed by 15 minutes.
How has the MTL Cannabis share price performed this year?
Shares in MTL Cannabis last closed at CA$0.33 and the price had moved by +29.41% over the past 365 days. In terms of relative price strength the MTL Cannabis share price has outperformed the Toronto Stock Exchange 300 Composite Index by +15.06% over the past year.
What are the analyst and broker recommendations for MTL Cannabis?
There is no consensus recommendation for this security.
Find out moreWhat is the MTL Cannabis dividend yield?
MTL Cannabis does not currently pay a dividend.
Does MTL Cannabis pay a dividend?
MTL Cannabis does not currently pay a dividend.
When does MTL Cannabis next pay dividends?
MTL Cannabis does not currently pay a dividend.
How do I buy MTL Cannabis shares?
To buy shares in MTL Cannabis you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of MTL Cannabis?
As of the previous close price of CA$0.33, shares in MTL Cannabis had a market capitalisation of CA$38.61m.
Where are MTL Cannabis shares listed?
Here are the trading details for MTL Cannabis:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: MTLC
What kind of share is MTL Cannabis?
Based on an overall assessment of its quality, value and momentum MTL Cannabis is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a MTL Cannabis share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the MTL Cannabis share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like MTL Cannabis. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +111.66%.
As of the last closing price of CA$0.33, shares in MTL Cannabis were trading +22.3% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the MTL Cannabis PE Ratio?
The MTL Cannabis PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.33.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of MTL Cannabis?
MTL Cannabis' management team is headed by:
- Christopher Churchill-Smith - CEO
- Paul Hart - CFO
- Fabian Daniel Henry - CEX
- Michael Orrbrooke - CEX
- Alex Kroon - EVP
- David Shpilt - VPR
- Steven Pearce - VPR
- Norman Betts - DRC
- Shawn Graham - DRC
- Gaetan Lussier - DRC
- Dennis Moir - DRC